相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Discovery of a new candidate drug to overcome cabazitaxel-resistant gene signature in castration-resistant prostate cancer by in silico screening
Hiroshi Hongo et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2023)
Circulating tumor cell gene expression and plasma AR gene copy number as biomarkers for castration-resistant prostate cancer patients treated with cabazitaxel
Giorgia Gurioli et al.
BMC MEDICINE (2022)
Cancer statistics, 2022
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2022)
Circ_0004087 interaction with SND1 promotes docetaxel resistance in prostate cancer by boosting the mitosis error correction mechanism
Liang Chen et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2022)
bub1 as a potential oncogene and a prognostic biomarker for neuroblastoma
Jingjing Song et al.
FRONTIERS IN ONCOLOGY (2022)
Comparative analysis of 1152 African-American and European-American men with prostate cancer identifies distinct genomic and immunological differences
Walter Rayford et al.
COMMUNICATIONS BIOLOGY (2021)
Hormonal Therapy for Prostate Cancer
Kunal Desai et al.
ENDOCRINE REVIEWS (2021)
Androgen receptor splicing variant 7 (ARV7) inhibits docetaxel sensitivity by inactivating the spindle assembly checkpoint
Bingbing Yu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2021)
BUB1 drives the occurrence and development of bladder cancer by mediating the STAT3 signaling pathway
Ning Jiang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)
Aneuploidy renders cancer cells vulnerable to mitotic checkpoint inhibition
Yael Cohen-Sharir et al.
NATURE (2021)
Whole-genome doubling confers unique genetic vulnerabilities on tumour cells
Ryan J. Quinton et al.
NATURE (2021)
Topoisomerase II alpha inhibition can overcome taxane-resistant prostate cancer through DNA repair pathways
Hiroshi Hongo et al.
SCIENTIFIC REPORTS (2021)
KIF4A knockdown suppresses ovarian cancer cell proliferation and induces apoptosis by downregulating BUB1 expression
Wumin Jin et al.
MOLECULAR MEDICINE REPORTS (2021)
Future prospects for mitosis-targeted antitumor therapies
Alfonso Serrano-del Valle et al.
BIOCHEMICAL PHARMACOLOGY (2021)
Inhibition of BUB1 suppresses tumorigenesis of osteosarcoma via blocking of PI3K/Akt and ERK pathways
Zhen Huang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2021)
LIN9 and NEK2 Are Core Regulators of Mitotic Fidelity That Can Be Therapeutically Targeted to Overcome Taxane Resistance
Melyssa S. Roberts et al.
CANCER RESEARCH (2020)
Androgen Receptor and Its Splicing Variant 7 Expression in Peripheral Blood Mononuclear Cells and in Circulating Tumor Cells in Metastatic Castration-Resistant Prostate Cancer
Mercedes Marin-Aguilera et al.
CELLS (2020)
TGFBR2 mediated phosphorylation of BUB1 at Ser-318 is required for transforming growth factor-β signaling
Shyam Nyati et al.
NEOPLASIA (2020)
Prostate Cancer 2020: The Times They Are a'Changing''
Alec Paschalis et al.
CANCER CELL (2020)
TGF-β causes Docetaxel resistance in Prostate Cancer via the induction of Bcl-2 by acetylated KLF5 and Protein Stabilization
Yixiang Li et al.
THERANOSTICS (2020)
Aneuploidy drives lethal progression in prostate cancer
Konrad H. Stopsack et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Genomic correlates of clinical outcome in advanced prostate cancer
Wassim Abida et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Arginine vasopressin receptor 1a is a therapeutic target for castration-resistant prostate cancer
Ning Zhao et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Polo-like kinase 1 (Plk1) inhibition synergizes with taxanes in triple negative breast cancer
Antonio Giordano et al.
PLOS ONE (2019)
Taxane-based Chemotherapy Induced Androgen Receptor Splice Variant 7 in Patients with Castration-Resistant Prostate Cancer: A Tissue-based Analysis
Myungsun Shim et al.
SCIENTIFIC REPORTS (2019)
Expression of AR-V7 and ARv567es in Circulating Tumor Cells Correlates with Outcomes to Taxane Therapy in Men with Metastatic Prostate Cancer Treated in TAXYNERGY
Scott T. Tagawa et al.
CLINICAL CANCER RESEARCH (2019)
Inhibition of BUB1 Kinase by BAY 1816032 Sensitizes Tumor Cells toward Taxanes, ATR, and PARP Inhibitors In Vitro and In Vivo
Gerhard Siemeister et al.
CLINICAL CANCER RESEARCH (2019)
Anti-mitotic therapies in cancer
Julia Tischer et al.
JOURNAL OF CELL BIOLOGY (2019)
Androgen receptor splice variant-7 expression emerges with castration resistance in prostate cancer
Adam Sharp et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Cotargeting Plk1 and androgen receptor enhances the therapeutic sensitivity of paclitaxel-resistant prostate cancer
Sol-Bi Shin et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2019)
Role of chemotherapy in prostate cancer
Rita Nader et al.
ASIAN JOURNAL OF ANDROLOGY (2018)
Establishment and characterization of two cabazitaxel-resistant prostate cancer cell lines
Kazuaki Machioka et al.
Oncotarget (2018)
Collateral resistance to taxanes in enzalutamide-resistant prostate cancer through aberrant androgen receptor and its variants
Masaki Shiota et al.
CANCER SCIENCE (2018)
Identification of an oncogenic network with prognostic and therapeutic value in prostate cancer
Fiorella Magani et al.
MOLECULAR SYSTEMS BIOLOGY (2018)
DESNT: A Poor Prognosis Category of Human Prostate Cancer
Bogdan-Alexandru Luca et al.
EUROPEAN UROLOGY FOCUS (2018)
Basis of catalytic assembly of the mitotic checkpoint complex
Alex C. Faesen et al.
NATURE (2017)
Phenotype transformation of immortalized NCM460 colon epithelial cell line by TGF-β1 is associated with chromosome instability
Chao Huang et al.
MOLECULAR BIOLOGY REPORTS (2016)
Substantial interindividual and limited intraindividual genomic diversity among tumors from men with metastatic prostate cancer
Akash Kumar et al.
NATURE MEDICINE (2016)
Probing the catalytic functions of Bub1 kinase using the small molecule inhibitors BAY-320 and BAY-524
Anna P. baron et al.
ELIFE (2016)
Association of AR-V7 on Circulating Tumor Cells as a Treatment-Specific Biomarker With Outcomes and Survival in Castration-Resistant Prostate Cancer
Howard I. Scher et al.
JAMA ONCOLOGY (2016)
The mitotic checkpoint protein kinase BUB1 is an engine in the TGF-β signaling apparatus
Aristidis Moustakas
SCIENCE SIGNALING (2015)
The kinase activity of the Ser/Thr kinase BUB1 promotes TGF-β signaling
Shyam Nyati et al.
SCIENCE SIGNALING (2015)
Androgen receptor splice variants circumvent AR blockade by microtubule-targeting agents
Guanyi Zhang et al.
ONCOTARGET (2015)
The mitotic checkpoint protein kinase BUB1 is an engine in the TGF-β signaling apparatus
Aristidis Moustakas
SCIENCE SIGNALING (2015)
The kinase activity of the Ser/Thr kinase BUB1 promotes TGF-β signaling
Shyam Nyati et al.
SCIENCE SIGNALING (2015)
Integration of copy number and transcriptomics provides risk stratification in prostate cancer: A discovery and validation cohort study
H. Ross-Adams et al.
EBIOMEDICINE (2015)
Androgen Receptor Splice Variants Determine Taxane Sensitivity in Prostate Cancer
Maria Thadani-Mulero et al.
CANCER RESEARCH (2014)
Targeting CDC25C, PLK1 and CHK1 to overcome Docetaxel resistance induced by loss of LZTS1 in prostate cancer
Nader Al Nakouzi et al.
ONCOTARGET (2014)
ERG induces androgen receptor-mediated regulation of SOX9 in prostate cancer
Changmeng Cai et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Cabazitaxel: More Than a New Taxane for Metastatic Castrate-Resistant Prostate Cancer?
Alain C. Mita et al.
CLINICAL CANCER RESEARCH (2012)
The mutational landscape of lethal castration-resistant prostate cancer
Catherine S. Grasso et al.
NATURE (2012)
NIH Image to ImageJ: 25 years of image analysis
Caroline A. Schneider et al.
NATURE METHODS (2012)
Taxane-Induced Blockade to Nuclear Accumulation of the Androgen Receptor Predicts Clinical Responses in Metastatic Prostate Cancer
Medha S. Darshan et al.
CANCER RESEARCH (2011)
BUB1 and BUBR1: multifaceted kinases of the cell cycle
Victor M. Bolanos-Garcia et al.
TRENDS IN BIOCHEMICAL SCIENCES (2011)
Integrative Genomic Profiling of Human Prostate Cancer
Barry S. Taylor et al.
CANCER CELL (2010)
Transforming growth factor β1 promotes chromosomal instability in human papillomavirus 16 E6E7-infected cervical epithelial cells
Wen Deng et al.
CANCER RESEARCH (2008)
The establishment of two paclitaxel-resistant prostate cancer cell lines and the mechanisms of paclitaxel resistance with two cell lines
Masashi Takeda et al.
PROSTATE (2007)
Merotelic kinetochore orientation occurs frequently during early mitosis in mammalian tissue cells and error correction is achieved by two different mechanisms
D Cimini et al.
JOURNAL OF CELL SCIENCE (2003)
Merotelic kinetochore orientation is a major mechanism of aneuploidy in mitotic mammalian tissue cells
D Cimini et al.
JOURNAL OF CELL BIOLOGY (2001)